Skip to main content

Minister and NHS questioned on regenerative medicine

1 December 2016

The Science and Technology Committee hold its third and final oral evidence session on regenerative medicine. This session will specifically focus on adoption of regenerative medicine therapies looking at NHS infrastructure, reimbursement, funding and strategic approach.


Wednesday 7 December 2016, Grimond Room, Portcullis House

At 9.20am

  • Dr Nick Crabb, Programme Director, Scientific Affairs, National Institute for Health and Care Excellence (NICE)
  • Dr Jonathan Fielden, Director of Specialised Commissioning and Deputy National Medical Director, NHS England
  • Dr James Palmer, Clinical Director of Specialised Commissioning, NHS England

At 10.05am

  • Dr Anthony Mathur, Professor of Cardiology, Queen Mary's School of Medicine and Dentistry
  • Professor Amit Nathwani, Professor of Haematology, Royal Free Hospital
  • Professor Giovanna Lombardi, Professor of Human Transplant Immunology, King's College London

At 10.50am

  • Lord Prior of Brampton, Parliamentary Under Secretary of State for Health, Department of Health


Further information

Image: iStockphoto